138 related articles for article (PubMed ID: 12883368)
21. CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies.
Helgadottir H; Höiom V; Tuominen R; Jönsson G; Månsson-Brahme E; Olsson H; Hansson J
Int J Cancer; 2015 Nov; 137(9):2220-6. PubMed ID: 25943250
[TBL] [Abstract][Full Text] [Related]
22. Targeted germline sequencing of patients with three or more primary melanomas reveals high rate of pathogenic variants.
Li C; Liu T; Tavtigian SV; Boucher K; Kohlmann W; Cannon-Albright L; Grossman D
Melanoma Res; 2020 Jun; 30(3):247-251. PubMed ID: 31567591
[TBL] [Abstract][Full Text] [Related]
23. Genetic variations of patients with familial or multiple melanoma in Southern Brazil.
Grazziotin TC; Rey MC; Bica CG; Pinto LA; Bonamigo RR; Puig-Butille JA; Cuellar F; Puig S
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e179-85. PubMed ID: 22621339
[TBL] [Abstract][Full Text] [Related]
24. Characterization of Potential Melanoma Predisposition Genes in High-Risk Brazilian Patients.
Soares de Sá BC; Moredo LF; Torrezan GT; Fidalgo F; de Araújo ÉSS; Formiga MN; Duprat JP; Carraro DM
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958811
[TBL] [Abstract][Full Text] [Related]
25. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.
Fargnoli MC; Altobelli E; Keller G; Chimenti S; Höfler H; Peris K
Melanoma Res; 2006 Apr; 16(2):175-82. PubMed ID: 16567973
[TBL] [Abstract][Full Text] [Related]
26. Melanoma in children and adolescents: analysis of susceptibility genes in 123 Italian patients.
Pellegrini C; Raimondi S; Di Nardo L; Ghiorzo P; Menin C; Manganoni MA; Palmieri G; Guida G; Quaglino P; Stanganelli I; Massi D; Pastorino L; Elefanti L; Tosti G; Queirolo P; Leva A; Maurichi A; Rodolfo M; Fargnoli MC;
J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):213-221. PubMed ID: 34664323
[TBL] [Abstract][Full Text] [Related]
27. Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations.
Scherer D; Nagore E; Bermejo JL; Figl A; Botella-Estrada R; Thirumaran RK; Angelini S; Hemminki K; Schadendorf D; Kumar R
Int J Cancer; 2009 Oct; 125(8):1868-75. PubMed ID: 19585506
[TBL] [Abstract][Full Text] [Related]
28. The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population.
Brudnik U; Branicki W; Wojas-Pelc A; Kanas P
Exp Dermatol; 2009 Feb; 18(2):167-74. PubMed ID: 18637131
[TBL] [Abstract][Full Text] [Related]
29. Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer.
Puig-Butille JA; Escámez MJ; Garcia-Garcia F; Tell-Marti G; Fabra À; Martínez-Santamaría L; Badenas C; Aguilera P; Pevida M; Dopazo J; del Río M; Puig S
Oncotarget; 2014 Mar; 5(6):1439-51. PubMed ID: 24742402
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of Familial Melanoma in Valencia, Spain, Based on the Presence of CDKN2A Mutations and MC1R Variants.
Huerta C; Garcia-Casado Z; Bañuls J; Moragon M; Oliver V; Unamuno B; Requena C; Kumar R; Nagore E
Acta Derm Venereol; 2018 Apr; 98(5):512-516. PubMed ID: 29405243
[TBL] [Abstract][Full Text] [Related]
31. Molecular characterization of melanoma cases in Denmark suspected of genetic predisposition.
Wadt KA; Aoude LG; Krogh L; Sunde L; Bojesen A; Grønskov K; Wartacz N; Ek J; Tolstrup-Andersen M; Klarskov-Andersen M; Borg Å; Heegaard S; Kiilgaard JF; Hansen TV; Klein K; Jönsson G; Drzewiecki KT; Dunø M; Hayward NK; Gerdes AM
PLoS One; 2015; 10(3):e0122662. PubMed ID: 25803691
[TBL] [Abstract][Full Text] [Related]
32. MC1R variants predisposing to concomitant primary cutaneous melanoma in a monozygotic twin pair.
Pellegrini C; Fargnoli MC; Suppa M; Peris K
BMC Med Genet; 2012 Sep; 13():81. PubMed ID: 22978401
[TBL] [Abstract][Full Text] [Related]
33. Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population.
Stratigos AJ; Dimisianos G; Nikolaou V; Poulou M; Sypsa V; Stefanaki I; Papadopoulos O; Polydorou D; Plaka M; Christofidou E; Gogas H; Tsoutsos D; Kastana O; Antoniou C; Hatzakis A; Kanavakis E; Katsambas AD
J Invest Dermatol; 2006 Aug; 126(8):1842-9. PubMed ID: 16601669
[TBL] [Abstract][Full Text] [Related]
34. CDKN2A mutations and melanoma risk in the Icelandic population.
Goldstein AM; Stacey SN; Olafsson JH; Jonsson GF; Helgason A; Sulem P; Sigurgeirsson B; Benediktsdottir KR; Thorisdottir K; Ragnarsson R; Kjartansson J; Kostic J; Masson G; Kristjansson K; Gulcher JR; Kong A; Thorsteinsdottir U; Rafnar T; Tucker MA; Stefansson K
J Med Genet; 2008 May; 45(5):284-9. PubMed ID: 18178632
[TBL] [Abstract][Full Text] [Related]
35. Characterization of individuals at high risk of developing melanoma in Latin America: bases for genetic counseling in melanoma.
Puig S; Potrony M; Cuellar F; Puig-Butille JA; Carrera C; Aguilera P; Nagore E; Garcia-Casado Z; Requena C; Kumar R; Landman G; Costa Soares de Sá B; Gargantini Rezze G; Facure L; de Avila AL; Achatz MI; Carraro DM; Duprat Neto JP; Grazziotin TC; Bonamigo RR; Rey MC; Balestrini C; Morales E; Molgo M; Bakos RM; Ashton-Prolla P; Giugliani R; Larre Borges A; Barquet V; Pérez J; Martínez M; Cabo H; Cohen Sabban E; Latorre C; Carlos-Ortega B; Salas-Alanis JC; Gonzalez R; Olazaran Z; Malvehy J; Badenas C
Genet Med; 2016 Jul; 18(7):727-36. PubMed ID: 26681309
[TBL] [Abstract][Full Text] [Related]
36. CDKN2A and MC1R variants influence dermoscopic and confocal features of benign melanocytic lesions in multiple melanoma patients.
Bassoli S; Maurichi A; Rodolfo M; Casari A; Frigerio S; Pupelli G; Farnetani F; Pelosi G; Santinami M; Pellacani G
Exp Dermatol; 2013 Jun; 22(6):411-6. PubMed ID: 23711066
[TBL] [Abstract][Full Text] [Related]
37. p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants.
Stefanaki I; Stratigos AJ; Dimisianos G; Nikolaou V; Papadopoulos O; Polydorou D; Gogas H; Tsoutsos D; Panagiotou P; Kanavakis E; Antoniou C; Katsambas AD
Br J Dermatol; 2007 Feb; 156(2):357-62. PubMed ID: 17223878
[TBL] [Abstract][Full Text] [Related]
38. MC1R variant alleles and malignant melanoma risk in Israel.
Galore-Haskel G; Azizi E; Mohamdi H; Scope A; Chaudru V; Laitman Y; Barak F; Pavlotsky F; Demenais F; Friedman E
Eur J Cancer; 2009 Jul; 45(11):2015-22. PubMed ID: 19269164
[TBL] [Abstract][Full Text] [Related]
39. Phenotypic and histologic characteristics of cutaneous melanoma in patients with melanocortin-1 receptor polymorphisms.
Avilés JA; Lázaro P; Fernández LP; Benítez J; Ibarrola-Villava M; Ribas G
Actas Dermosifiliogr; 2012 Jan; 103(1):44-50. PubMed ID: 22464597
[TBL] [Abstract][Full Text] [Related]
40. MC1R genotypes and risk of melanoma before age 40 years: a population-based case-control-family study.
Cust AE; Goumas C; Holland EA; Agha-Hamilton C; Aitken JF; Armstrong BK; Giles GG; Kefford RF; Schmid H; Hopper JL; Mann GJ; Jenkins MA
Int J Cancer; 2012 Aug; 131(3):E269-81. PubMed ID: 22095472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
